Immuron Ltd. Files August 2024 Report (6-K)
Ticker: IMRN · Form: 6-K · Filed: Aug 21, 2024 · CIK: 1660046
| Field | Detail |
|---|---|
| Company | Immuron LTD (IMRN) |
| Form Type | 6-K |
| Filed Date | Aug 21, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
Immuron Ltd. filed its August 6-K, confirming it's a foreign private issuer reporting under 20-F.
AI Summary
On August 21, 2024, Immuron Ltd. filed a Form 6-K, reporting its activities for August 2024. The filing indicates the company is a foreign private issuer and will file annual reports under Form 20-F. No specific financial figures or new developments were detailed in the provided excerpt.
Why It Matters
This filing provides an update on Immuron Ltd.'s regulatory reporting status with the SEC, indicating ongoing compliance for investors.
Risk Assessment
Risk Level: low — This filing is a routine regulatory update and does not contain new material financial information or significant business changes.
Key Players & Entities
- Immuron Ltd (company) — Registrant
- August 2024 (date) — Reporting period
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information that Immuron Limited has made or is required to make public in Australia, or has distributed or made available to its security holders, during the month of August 2024.
Does Immuron Limited file annual reports under Form 20-F or Form 40-F?
Immuron Limited indicates it files annual reports under cover of Form 20-F.
Is Immuron Limited furnishing information under Rule 12g3-2(b)?
No, Immuron Limited is not furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
What is the principal executive office address of Immuron Limited?
The principal executive office address of Immuron Limited is Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
What is the SIC code for Immuron Limited?
The Standard Industrial Classification (SIC) code for Immuron Limited is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 314 words · 1 min read · ~1 pages · Grade level 18.6 · Accepted 2024-08-21 09:28:04
Filing Documents
- ea0212015-6k_immuron.htm (6-K) — 13KB
- ea021201501ex99-1_immuron.htm (EX-99.1) — 39KB
- ex99-1_001.jpg (GRAPHIC) — 37KB
- ex99-1_002.jpg (GRAPHIC) — 13KB
- ex99-1_003.jpg (GRAPHIC) — 24KB
- ex99-1_004.jpg (GRAPHIC) — 716KB
- ex99-1_005.jpg (GRAPHIC) — 810KB
- ex99-1_006.jpg (GRAPHIC) — 853KB
- ex99-1_007.jpg (GRAPHIC) — 543KB
- ex99-1_008.jpg (GRAPHIC) — 772KB
- ex99-1_009.jpg (GRAPHIC) — 1317KB
- ex99-1_010.jpg (GRAPHIC) — 697KB
- ex99-1_011.jpg (GRAPHIC) — 728KB
- ex99-1_012.jpg (GRAPHIC) — 726KB
- ex99-1_013.jpg (GRAPHIC) — 906KB
- ex99-1_014.jpg (GRAPHIC) — 610KB
- ex99-1_015.jpg (GRAPHIC) — 916KB
- ex99-1_016.jpg (GRAPHIC) — 343KB
- 0001213900-24-071287.txt ( ) — 13842KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of August 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on August 21, 2024 titled: - “Immuron CEO presentation to Peak Biotech Showcase” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Immuron CEO presentation to Peak Biotech Showcase 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: August 21, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3